Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study.

MLA

Vegezzi, Elisa, et al. “Muscle Quantitative MRI as a Novel Biomarker in Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Cross-Sectional Study.” Journal of Neurology, vol. 270, no. 1, Jan. 2023, pp. 328–39. EBSCOhost, https://doi.org/10.1007/s00415-022-11336-z.

APA

Vegezzi, E., Cortese, A., Bergsland, N., Mussinelli, R., Paoletti, M., Solazzo, F., Currò, R., Ascagni, L., Callegari, I., Quartesan, I., Lozza, A., Deligianni, X., Santini, F., Marchioni, E., Cosentino, G., Alfonsi, E., Tassorelli, C., Bastianello, S., Merlini, G., & Palladini, G. (2023). Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study. Journal of Neurology, 270(1), 328–339. https://doi.org/10.1007/s00415-022-11336-z

Chicago

Vegezzi, Elisa, Andrea Cortese, Niels Bergsland, Roberta Mussinelli, Matteo Paoletti, Francesca Solazzo, Riccardo Currò, et al. 2023. “Muscle Quantitative MRI as a Novel Biomarker in Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Cross-Sectional Study.” Journal of Neurology 270 (1): 328–39. doi:10.1007/s00415-022-11336-z.